Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04482374 · ClinicalTrials.gov registry record
Puberty Suppression and Cardiometabolic Health
A clinical trial of Endothelial Dysfunction and Vascular Stiffness, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT04482374 is a study of Endothelial Dysfunction and Vascular Stiffness that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 30 participants, below the 92-participant average among 45 other Endothelial Dysfunction trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04482374, a study of Endothelial Dysfunction and Vascular Stiffness, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This observational study will evaluate the effect of puberty suppression on insulin sensitivity, metabolic rate and vascular health among transgender female youth at baseline and 6 months after initiation of a gondoatropin releasing hormone agonist compared to matched cisgender male controls.
Conditions Studied
Study Locations (1)
Colorado
- University of Colorado Anschutz Medical Campus - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2020-08-10 |
| Est. Completion | 2026-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04482374
The ClinicalTrials.gov registry entry for NCT04482374 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 92-participant average among 45 other Endothelial Dysfunction trials with a reported enrollment target (67% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Endothelial Dysfunction appearing as the primary indexed condition, and to 0 interventions.
NCT04482374 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT04482374 about?
NCT04482374 is a clinical study titled "Puberty Suppression and Cardiometabolic Health". This observational study will evaluate the effect of puberty suppression on insulin sensitivity, metabolic rate and vascular health among transgender female youth at baseline and 6 months after initiation of a gondoatropin releasing hormone agonist compared to matched cisgender male controls.
What is the current status of trial NCT04482374?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2020-08-10. Estimated completion is 2026-07-31.
What conditions does trial NCT04482374 study?
This clinical trial studies the following conditions: Endothelial Dysfunction, Vascular Stiffness, Transgenderism, Insulin Sensitivity/Resistance.
Who is sponsoring clinical trial NCT04482374?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04482374 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endothelial Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
RECRUITING · Phase 1
-
Effect of a Daily Supplement on Plasma PAI-1 Levels
RECRUITING · Phase 1
-
Role of Endothelial Function in SCI CVD Risk
RECRUITING
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Role of ET-1, Physical Activity, and Sedentary Behavior in Microvascular Dysfunction Following GDM
RECRUITING · Early Phase 1
-
B-Complex: A Nutraceutical SANS Countermeasure
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.